:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Kidney Cancer News
Kidney Cancer Breakthrough News
 

May 22, 2012
ASCO: Novel Anti-VEGF Drug Effective in Kidney Cancer

  By John Gever, Senior Editor, MedPage Today

CHICAGO -- An investigational drug targeting all three forms of the vascular endothelial growth factor (VEGF) receptor was more effective against advanced renal cell carcinoma than a current standard agent, researchers found.   <READ MORE>

 

Oct 7, 2008
Benefits of Sorafenib Cover Age Range in Kidney Cancer

  By Todd Neale, Staff Writer, MedPage Today

CAMBRIDGE, England, Oct. 7 -- For advanced renal cell carcinoma, sorafenib (Nexavar) improves outcomes in both younger and older patients, according to a post-hoc analysis.   <READ MORE>

 

Sept 30, 2008
KCA: Effectiveness of Sunitinib in Kidney Cancer Comes at a Price

  By John Gever, Staff Writer, MedPage Today

CHICAGO, Sept. 30 -- Sunitinib (Sutent) is considerably more toxic than interferon-alpha in first-line systemic treatment of metastatic kidney cancer patients, though it is also more effective, researchers reported here.  <READ MORE>

 

Sept 30, 2008
KCA: Everolimus Doubles Progression-Free Survival in Metastatic Kidney Cancer

  By John Gever, Staff Writer, MedPage Today

CHICAGO, Sept. 30 -- The investigational drug everolimus (RAD001) may delay progression of metastatic kidney cancer more than previously reported, researchers said here.  <READ MORE>

 

Sept 29, 2008
KCA: Tumor-Reducing Surgery Boosts Drug Effect in Metastatic Kidney Cancer

  By John Gever, Staff Writer, MedPage Today

CHICAGO, Sept. 29 -- For patients with metastatic kidney cancer, anti-angiogenesis therapy with sunitinib (Sutent) was more effective in those who had had cytoreductive surgery than in those who did not, researchers said here.  <READ MORE>

 

Sept 29, 2008
KCA: Mixed Results on Investigational VEGF Inhibitor

  By John Gever, Staff Writer, MedPage Today

CHICAGO, Sept. 29 -- Cediranib (Recentin), an investigational anti-angiogenesis drug for renal cell carcinoma, showed favorable interim efficacy results in a phase II trial, it was reported here, but safety questions may remain.  <READ MORE>

 

July 23, 2008
Kidney Cancer Progression Slowed by mTOR Inhibitor

  By Charles Bankhead, Staff Writer, MedPage Today

NEW YORK, July 23 -- Patients with advanced renal cell carcinoma had a two-fold improvement in progression-free survival when treated with an investigational mTOR inhibitor after failure of targeted therapy, results of a phase III clinical trial showed.  <READ MORE>

 

June 2, 2008
Vaccine Therapy Disappoints for Kidney Cancer

  By Crystal Phend, Staff Writer, MedPage Today

HOUSTON, July 3 -- The tumor-derived vaccine vitespen (Oncophage) does not prevent renal-cell carcinoma recurrence or improve survival despite promising early results, researchers said.  <READ MORE>

 

June 2, 2008
ASCO: Two-Year Survival Seen with Sunitinib (Sutent) in Advanced Kidney Cancer

  By Peggy Peck, Executive Editor, MedPage Today

CHICAGO, June 2 -- In patients with treatment-naive advanced renal cell carcinoma, treatment with sunitinib (Sutent) more than doubled progression-free survival compared with interferon alfa.  <READ MORE>

 

May20, 2008
Early Diagnosis of Renal Cell Carcinoma is Increasing

  By Todd Neale, Staff Writer, MedPage Today

SAN DIEGO, May 20 -- Renal cell carcinoma is being diagnosed earlier than it was more than a decade ago, researchers here found.  <READ MORE>

 

May16, 2008
ASCO: mTOR Inhibitor Delays Progression of Metastatic Renal Cell Carcinoma 

  By Michael Smith, North American Correspondent, MedPage Today

NEW YORK, May 16 -- More than 60% of metastatic kidney cancer patients taking an investigational mTOR inhibitor had a delay in progression of their disease, researchers here said.  <READ MORE>

 

Mar 25, 2008
Kidney Sparing Surgery Almost Always Feasible for Wilms' Tumor 

  By Crystal Phend, Staff Writer, MedPage Today

MEMPHIS, Tenn., March 25 -- Kidney sparing surgery may be an option for children with bilateral Wilms' tumors even when imaging shows extensive disease, researchers here found.  <READ MORE>

 

Mar 18, 2008
SIR: Percutaneous Cryoablation Effective Against Kidney Cancer 

  By Michael Smith, North American Correspondent, MedPage Today

WASHINGTON, March 18 -- Percutaneous cryoablation stops kidney cancer cold, researchers said here.  <READ MORE>

 

Mar 10, 2008
Kidney Cancer Surgeons Snub Innovations and Stick to Old Ways 

  By Todd Neale, Staff Writer, MedPage Today

LOS ANGELES, March 10 -- For kidney cancer patients, surgeons have been slow to adopt innovative procedures with apparent advantages, researchers here found.  <READ MORE>

 

Feb 28, 2008
Clear Benefit from Everolimus Brings Kidney Cancer Trial to a Halt

  By Peggy Peck, Executive Writer, MedPage Today

EAST HANOVER, N.J., Feb. 28 -- Progression-free survival was significantly extended in kidney cancer patients who took everolimus (RAD001), an investigational, targeted drug taken as a daily tablet, according to Novartis Pharmaceuticals. <READ MORE>

 

Feb 14, 2008
ASCO GU: American Society of Clinical Oncology-Genitourinary Cancer Symposium Meeting

  By Crystal Phend, Staff Writer, MedPage Today

SAN FRANCISCO, Feb. 14 -- Few eligible patients with small renal tumors are offered kidney-sparing surgery rather than radical nephrectomy, researchers said here. <READ MORE>

 

August 30, 2007
PODCAST: Recent Developments in the Treatment of Renal Cell Carcinoma

  By Charles Bankhead, Staff Writer, MedPage Today

In this exclusive podcast with Medpage Today, Nazar M. Tannir, M.D., of the University of Texas M.D. Anderson Cancer Center in Houston, reviews recent developments in the treatment of kidney cancer. In particular, Dr. Tannir focuses on new and emerging targeted therapies for renal cell carcinoma in his discussion with Medpage Today Staff Writer Charles Bankhead.  <READ MORE>

 

August 30, 2007
Another VEGF Inhibitor Shows Activity Against Kidney Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

PARIS, Oct. 30 -- Treatment with axitinib resulted in at least a partial response in nearly half of patients with cytokine-refractory metastatic kidney cancer, investigators in a multinational trial have found. <READ MORE>

 

August 01, 2007
Radiofrequency Ablation Wipes Out Small Kidney Tumors

  By Judith Groch, Senior Writer, MedPage Today

WINSTON-SALEM, N.C., Aug. 1 -- One-time percutaneous radiofrequency ablation proved completely successful in eradicating small malignant kidney lesions, found researchers here. <READ MORE>

 

:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough News ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

 
Copyright ⓒ ICare.  All rights reserved.